Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $701449.0.

  • Lipocine's Cash from Investing Activities fell 3139.68% to $701449.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 1515.93%. This contributed to the annual value of $2.4 million for FY2024, which is 8130.59% down from last year.
  • According to the latest figures from Q3 2025, Lipocine's Cash from Investing Activities is $701449.0, which was down 3139.68% from $4.5 million recorded in Q2 2025.
  • Lipocine's Cash from Investing Activities' 5-year high stood at $7.3 million during Q1 2022, with a 5-year trough of -$34.0 million in Q1 2021.
  • Over the past 5 years, Lipocine's median Cash from Investing Activities value was $1.2 million (recorded in 2023), while the average stood at -$507187.7.
  • Per our database at Business Quant, Lipocine's Cash from Investing Activities plummeted by 97115.06% in 2021 and then soared by 36452.93% in 2022.
  • Lipocine's Cash from Investing Activities (Quarter) stood at -$9.7 million in 2021, then surged by 126.7% to $2.6 million in 2022, then grew by 5.02% to $2.7 million in 2023, then crashed by 72.09% to $761058.0 in 2024, then decreased by 7.83% to $701449.0 in 2025.
  • Its Cash from Investing Activities stands at $701449.0 for Q3 2025, versus $4.5 million for Q2 2025 and -$882073.0 for Q1 2025.